If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:99755-59-6
Source:Europe
Qualifications:-/-/-/-/-
Name | Rotigotine/Rotigotine |
---|---|
Chinese name | 罗替高汀/罗替戈汀 |
Cas Number | 99755-59-6 |
Source | Europe |
Qualifications | -/-/-/-/- |
The original research is UCB pharma, which was first listed in the UK in 2006 and in the US in 2007. It has been listed in 44 countries or regions including Canada, Japan, France, Germany, and Italy. Rotigotine belongs to the class of non-ergot selective dopamine receptor agonists. It acts by stimulating the dopamine receptors in the body and mimicking the neurotransmitter dopamine. This product is the world's first transdermal patch for the treatment of Parkinson's disease. It is different from the route of administration of all treatment programs on the market. Rotigotine can significantly improve the patient's condition. The transdermal patch can continuously release the drug to avoid frequent Occurs in a sudden "interrupted" state of oral medication. The launch of Rotigotine provides new treatment options for patients and their families affected by this chronic disease, helping patients with Parkinson's disease regain a comfortable and quality life.
Hot Tags: rotigotine/rotigotine api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bivalrudine API, Tippyridine Hydrochloride API, Oseltamivir Phosphate API, Itraconazole Hydrochloride API, Letrozole API, Lifitegrast API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China